Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • Drug Charts
    • Do Not Crush List
    • First-Time Generics
    • Insulin Safety
    • New Drugs
    • Original Container Meds
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes

Diabetes

  • Diabetes (716)
    • Blood Glucose Meters (12)
    • Complications (120)
    • Diabetes in Pregnancy (6)
    • Diabetes Meds (79)
    • Drug-Induced Hypo/Hyperglycemia (103)
    • Monitoring (99)
    • Natural Medicines/Supplements (12)
    • Prevention (32)
    • Treatment (282)
  • Endocrinology (7)
  • Hyperglycemia (34)
  • Hypoglycemia (16)
  • Other (20)
  • Prediabetes (2)
  • Resources (165)
  • Thyroid Disorders (60)
136 - 150 of 716 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Understand How "Basal" Insulins for Type 2 Diabetes Compare September 2017
Guideline: American Diabetes Association Diabetic Neuropathy Position Statement (2017) September 2017
Commentary: Overview of Nonalcoholic Fatty Liver Disease September 2017
Chart: Insulin Analogs vs Human Insulin September 2017
Article: Expect to See Fewer Rxs for Short Courses of Oral Steroids July 2017
Article: Watch for Labeling Changes About Amputations With Invokana July 2017
Other: Risk of Amputations With Canagliflozin July 2017
Commentary: Risks of Short-Course Steroids July 2017
Article: Think of Xultophy as Similar to Soliqua for Type 2 Diabetes June 2017
Algorithm: Stepwise Treatment of Hypertension (Canada)

June 2017
Patient Education: Fish Oil and Other Omega-3 Fatty Acids May 2017
Article: Look for Ways to Help Diabetes Patients With Rising Insulin Costs March 2017
Algorithm: Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes March 2017
Article: Expect Most Patients With Type 2 Diabetes to Need a Metformin Add-On February 2017
Article: Adlyxin and Soliqua Join a Crowded Market of Injectable Diabetes Meds January 2017
  • « Prev
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved